Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients

Table 3 Univariate analysis of Ki67 change and clinic-pathological factors

Clinic-pathological factors	P value
Age	0.521
Menopause status	0.638
Tumor size	0.658
Lymph node status	0.358
Estrogen receptor^a	0.529
Progesterone receptor^a	0.585
HER2^a	0.569
Molecular subtype^a	0.030
Surgery time interval	0.007

^aExpression status in CNB sample
Univariate ANOVA analysis used to analyze association between Ki67 change and clinico-pathological factors

ISSN: 1471-2407